Table 7.

Multivariate predictors of ‘definitely’ wanting a prostate‐specific antigen (PSA) screening test in next 12 months

Variable	Unadjusted odds ratio (95%CI)	P‐value	Adjusted odds ratio (95%CI)	P‐value
LUTS*	1.20 (1.08–1.34)	0.001	1.15 (1.02–1.29)	0.02
0 or 1 symptoms†	1.00		1.00
Two or more symptoms	1.82 (1.26–2.64)		1.53 (1.01–2.30)
Worried about prostate cancer
A little to a lot	1.85 (1.28–2.68)	0.001	1.71 (1.14–2.56)	0.01
Not worried†	1.00		1.00
Know person with prostate cancer
Yes	1.79 (1.23–2.59)	0.002	1.60 (1.07–2.39)	0.02
No†	1.00		1.00
Convinced of benefit of PSA screening
Very/somewhat unconvinced to neither†	1.50 (0.95–2.36)	<0.001	1.00	<0.001
Somewhat convinced	5.32 (3.23–8.75)		1.15 (0.71–1.88)
Very convinced	1.00		3.74 (2.16–6.46)
Views towards screening*	1.83 (1.48–2.26)	<0.001	1.47 (1.16–1.86)	0.001
−4 to 2‡	1.00		1.00
2.1–4	2.39 (1.65–3.46)		1.68 (1.12–2.52)
Chance health locus of control score*	0.84 (0.69–1.02)	0.07	0.81 (0.66–1.01)	0.06
1–3†	1.00		1.00
4–6	0.71 (0.50–1.03)		0.70 (0.47–1.05)

*Modelled as continuous.

^†Referent group.

^‡Categories based on median split of data.